+963930660074 [email protected]
  • المستحضرات الدوائية
  • المتممات الغذائية
  • المستحضرات الصحية و التجميلية
Vita Pharma
  • جميع المنتجات
  • الصفحة الرئيسية
  • مقالات
Select Page
FDA Approves Once-Daily Jentadueto XR (linagliptin and metformin hydrochloride extended-release) for Type 2 Diabetes

FDA Approves Once-Daily Jentadueto XR (linagliptin and metformin hydrochloride extended-release) for Type 2 Diabetes

by Vita | Jun 2, 2016 | Articles

Ridgefield, Conn., and Indianapolis, May 31, 2016 – The U.S. Food and Drug Administration (FDA) has approved Jentadueto XR (linagliptin and metformin hydrochloride extended-release) tablets for the treatment of type 2 diabetes (T2D) in adults. Jentadueto XR, which is...
Low salt intake may raise risk of heart attack, stroke, and death

Low salt intake may raise risk of heart attack, stroke, and death

by Vita | May 21, 2016 | Articles

A high salt intake has been linked to increased blood pressure and greater risk for heart problems. But according to new research, low salt intake may be just as harmful. Researchers suggest only people with high blood pressure who have a high salt intake should...

Tags

antibiotics baby children Diabetes FDA Globivite heart memory new pregnancy Supplement virus اطفال الالم البدانة البرد التهاب الحمل الحمية الصيدلة الطب الطفل العصب العظام العلوم المستقبل النانو النمو بكتيريا رينو سرطان صحة صمم علاج غلوبيفيت فقر الدم فيتامينات فيروس قلب لقاح متلازمة متممات مقاومة مندوب دعاية وظيفة
Powered by AZ-360  | Copyright © 2025  |   www.vita-sy.com